Overexpression of p53 protein in betel‐ and tobacco‐related human oral dysplasia and squamous‐cell carcinoma in India

International Journal of Cancer

Volumn 58, Issue 3, 1994, Pages 340-345

  Kaur, Jasbir ^a   Srivastava, Anurag ^a   Ralhan, Ranju ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; BETEL NUT; CONTROLLED STUDY; DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDIA; MAJOR CLINICAL STUDY; MOUTH CANCER; PRIORITY JOURNAL; TOBACCO; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; ARECA; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INDIA; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGE; MOUTH MUCOSA; MOUTH NEOPLASMS; PLANTS, MEDICINAL; PLANTS, TOXIC; PRECANCEROUS CONDITIONS; PRECIPITIN TESTS; PROTEIN P53; SUPPORT, NON-U.S. GOV'T; TOBACCO, SMOKELESS;

EID: 0028106313     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910580305     Document Type: Article

References (32)

1. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node‐negative breast cancer
2. Isolation of human‐p53‐specific monoclonal antibodies and their use in the studios of human p53 expression
3. Low risk areas of the world
4. The incidence of p53 mutations increases with progression of head and neck cancer
5. Epidemiology of mouth cancer in 1989: a review
6. Detection of p53 in primary lung tumours and non‐small‐cell lung carcinoma cell lines
7. p53 alterations in human squamous cell carcinomas and carcinoma cell lines
8. p53 expression in breast cancer
9. Ras mutations in United Kingdom examples of oral malignancies are infrequent
10. The situation in high risk areas of the world
11. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck
12. Overexpression of p53 gene in head and neck cancer, linked with heavy smoking and drinking
13. Monoclonal antibodies specific for simian virus 40 tumour antigens
14. p53 mutations in human cancers
15. Use of avidin‐biotin peroxidase complex (ABC) in immunoperoxidase techniques a comparison between ABC and unlabelled antibody (PAP) procedures
16. p53 and c‐erb B‐2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder
17. p53: Oncogene or anti‐oncogene?
18. Expression of the tumour‐suppressor gene p53 in oral cancer
19. The p53 tumor‐suppressor gene
20. Expression of mutated p53 occurs in tumor‐distant epithelia of head‐and‐neck cancer patients: a possible molecular basis for the development of multiple tumors
21. Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas
22. Assessment of p53 protein expression in normal, benign and malignant oral mucosa
23. p53 expression in dyskeratosis congenita: a marker for oral premalignancy?
24. Epidemiological studies of oral cancer
25. Some oral carcinomas from Sri Lankan betel/tobacco chewers overexpress p53 oncoprotein but lack mutations in exons 5‐9
26. Low prevalence of expression of p53 oncoprotein in oral carcinomas from Sri Lanka associated with betel and tobacco chewing
27. Low incidence of ras oncogene activation in human squamous cell carcinomas
28. The p53 tumor‐suppressor gene and ras oncogene mutations in oral squamous cell carcinoma
29. Epidemiologic and intervention studies. Screening: cancer epidemiology: the Indian scene
30. High frequency mutation in codons 12 and 61 of H‐ras oncogene in chewing‐tobacco‐related human oral carcinoma in India
31. Precise epitope mapping of the murine transformation associated protein, p53
32. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions